NCT00222378View on ClinicalTrials.gov

Prevalence of Cytomegalovirus, Epstein Barr Virus and Human Herpes 6 Virus in Inflammatory Bowel Disease

CompletedOBSERVATIONAL

Enrollment

129

Participants

Timeline

Start Date

April 30, 2005

Primary Completion Date

June 30, 2012

Study Completion Date

June 30, 2012

Conditions

Crohn's DiseaseUlcerative Colitis

Trial Locations (1)

33136

Jackson Memorial Hospital, Miami

All Listed Sponsors

collaborator

Hoffmann-La Roche

INDUSTRY

lead

University of Miami

OTHER

NCT00222378 - Prevalence of Cytomegalovirus, Epstein Barr Virus and Human Herpes 6 Virus in Inflammatory Bowel Disease | Biotech Hunter | Biotech Hunter